EcoDrugPlus

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSNBRG00000009614
Gene Symbol: PTK6B
1 Cross references
159 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSNBRG00000018222
Gene Symbol: LOC102791840
3 Cross references
209 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSNBRG00000005228
Gene Symbol: LOC102795216
3 Cross references
161 Possible Orthologues:

Rac-Gamma Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSNBRG00000013765
Gene Symbol: LOC102786020
3 Cross references
203 Possible Orthologues:

Raf Proto-Oncogene Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSNBRG00000022128
Gene Symbol: LOC102780128
3 Cross references
207 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSNBRG00000007194
Gene Symbol: SRC
4 Cross references
192 Possible Orthologues:

Tgf-Beta Receptor Type-1-Like

Ensembl ID : ENSNBRG00000015485
Gene Symbol: LOC102779975
3 Cross references
202 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSNBRG00000014747
Gene Symbol: YES1
4 Cross references
208 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSNBRG00000002532
Gene Symbol: ACHE
1 Cross references
231 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSNBRG00000013682
Gene Symbol: ACVR2B
3 Cross references
195 Possible Orthologues:

Activin A Receptor Type 2ba

Ensembl ID : ENSNBRG00000013038
Gene Symbol: ACVR2BA
1 Cross references
193 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSNBRG00000013258
Gene Symbol: ADORA1
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).